What does BPC-157 TB-500 do in research?

In published studies, each peptide was tested on its own, mostly in rats and cell cultures. BPC-157 activated VEGFR2, a receptor that drives new blood vessel growth, and improved healing measures after rat Achilles tendons or knee ligaments were cut. Thymosin beta-4, the sequence sold as TB-500, binds actin and sped wound closure in a rat skin model, with more collagen and blood vessels than controls.

Researchers study the pair to see whether those two routes add up in one tissue repair model. No peer-reviewed study has tested the combination yet, and none of the data describe effects in people. Read our research purposes only policy, then view the specs for the Wolverine stack.

wolverine stack blend of bpc 157 and tb 500
BPC-157/TB-500